Patient Guide: Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 114 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06921785
Status: 🟢 Enrolling Now
Condition: Hepatocellular Carcinoma
Phase: PHASE3

Where You Can Participate

This study is available at 114 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Palo Alto, California
  • • New Haven, Connecticut
  • • And 111 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma - Join Clinical Trial NCTNCT06921785

How to Join This Clinical Trial - NCTNCT06921785

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hepatocellular Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hepatocellular Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hepatocellular Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06921785 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 114 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: WITHDRAWN

Clinical Research Site

Grand Rapids, Michigan 49503 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New Brunswick, New Jersey 08901 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Arlington, Virginia 22201 - United States

Status: NOT_YET_RECRUITING

And 104 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hepatocellular Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships